Case Presentations: Missed Opportunities
This event has passed and can no longer be viewed
This event was presented live or live-streamed and has not been designated for on-demand presentation.
This Department of Family and Community Medicine Grand Rounds session will take place on Tuesday, February 13, 2024 at 5:30 p.m. Attendance will be available remotely through Zoom.
Activity Information
Needs Statement
Primary care physicians, fellows, residents, physician assistants, nurse practitioners, and other primary care providers need to receive regular updates on evidence-based guidelines, medication standards, and research advances in the field of primary care. The series serves as a platform to discuss collaborative practice issues such as integrated care, subspecialty referrals, and process improvement of chronic, acute, and preventive care. The series aims to expand the knowledge of learners, improve their clinical skills and competencies, enhance the quality of primary care, and improve patient outcomes.
Educational Objectives
An Algorithm-Driven Intervention: A Case Study in Renal Cancer Management
At the conclusion of the session, the participants should be able to:
- Recognize the importance of a timely diagnosis of renal cancer.
- Review the risk assessment for renal cancel.
- Apply the diagnostic algorithm for microscopic hematuria to detect renal cancer.
- Evaluate data on outcomes of an early versus a late diagnosis of renal cancer.
Timely Identification and Treatment: Lessons from a Case of Abdominal Actinomycetes
At the conclusion of the session, the participants should be able to:
- Recognize the rarity of infections caused by Actinomyces spp.
- Identify clinical presentations of actinomycosis.
- Outline the diagnostic criteria for actinomycosis.
- Review current treatment approaches for actinomycosis.
Target Audience
Professional Categories
- Physicians
- Residents
- Nurses
- Other Health Professionals
Specialties
- Family and Community Medicine
Interest Groups
- Primary Care
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Director
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenters
-
Rekha Afzalpurkar, M.D.
Assistant Professor of Family and Community Medicine
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Nidhi Mehrotra, M.B.B.S.
Assistant Professor of Family and Community Medicine
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Activity Director
-
Malvika Juneja, M.D.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
William Y Huang, M.D.
Associate Professor and Vice Chair of Education
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Malvika Juneja, M.D.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Fareed M. Khan, M.D.
Associate Professor and Vice Chair
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Eric Lee, M.D.
Assistant Professor of Family and Community Medicine
Baylor College of Medicine
Disclosure:
- Ownership Interests (stock, stock options, excluding diversified mutual funds): Bristol-Myers Squibb (stockholder)